Invitro Biotech Limited, a active public limited company, was established on 18 July 2001 in Hyderabad, Telangana, India. Engaging in medical equipment retail & distribution within the manufacturing sector, it holds CIN: U29219TG2001PLC037037. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Formerly known as Invitro Biotech Private Limited. It upholds a compliant status. Its leadership includes Sujata Malik (Director), Jeniva Malik (Director), Chandra Vijay Malik (Director). Past directors included Sujata Malik, Jonnalagadda Sudha Lakshmi, Nalin Vijay Malik. It holds no open charges and ₹0.80 M settled loans. Its latest AGM occurred on 07 December 2020, with the balance sheet filed on 31 March 2020. It is based at 507, 5 Th Floor, Mayuri Hills, Mayuri Nagar , Miyapur, Hyderabad, Telangana, 500049.
U29219TG2001PLC037037
037037
18 July 2001
₹0.50 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Invitro Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujata Malik | Director | 22 Jan 2016 | Current |
| Jeniva Malik | Director | 18 Jul 2001 | Current |
| Chandra Vijay Malik | Director | 18 Jul 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 15 Nov 2015 | Past |
| Pramod Abcsdd | Director | 22 Nov 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Invitro Biotech Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 32.92% decrease. The company also saw a substantial fall in profitability, with a 743.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 95.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Invitro Biotech had a promoter holding of 55.00% and a public holding of 45.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Nov 2001 | Bank Of Baroda | ₹0.80 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Invitro Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Invitro Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invitro Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Invitro Biotech Limited last Annual general meeting of members was held on 07 Dec 2020 as per latest MCA records. was completed.
Progress on Invitro Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was documented.
The activity Sujata Malik was appointed as a Director was appointed as a Director on 22 Jan 2016 & has been associated with this company since 9 years 10 months . was completed.
The activity A charge registered on 12 Nov 2001 via Charge ID 90126482 with Bank Of Baroda was fully satisfied on 27 Apr 2015. was completed.
A charge with Bank Of Baroda amounted to Rs. 0.80 M with Charge ID 90126482 was registered on 12 Nov 2001. was recorded as a recent event.
Jeniva Malik was appointed as a Director was appointed as a Director on 18 Jul 2001 & has been associated with this company since 24 years 5 months . was recorded as a recent event.
The CIN of Invitro Biotech Limited is U29219TG2001PLC037037.
Invitro Biotech Limited is headquartered at 507, 5 Th Floor, Mayuri Hills, Mayuri Nagar , Miyapur, Hyderabad, Telangana, 500049.
Invitro Biotech Limited was incorporated on 18 July 2001.
The current directors of Invitro Biotech Limited are
The primary industry of Invitro Biotech Limited is Manufacturing.
Invitro Biotech Limited is unlisted.
The authorized capital of Invitro Biotech Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Invitro Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX